Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Arrhythmias

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 248 articles:
HTML format
Text format



Single Articles


    June 2018
  1. SHARMA A, Hijazi Z, Andersson U, Al-Khatib SM, et al
    The Use of Biomarkers to Predict Specific Causes of Death in Patients with Atrial Fibrillation: Insights from the ARISTOTLE Trial.
    Circulation. 2018 Jun 5. pii: CIRCULATIONAHA.118.034125.
    PubMed     Text format     Abstract available



  2. Correction to: Ventricular Tachycardia Ablation in Patients With Implantable Cardioverter Defibrillators Should No Longer Be a Therapy of Last Resort.
    Circulation. 2018;137:e842.
    PubMed     Text format    


  3. ROWIN EJ, Maron MS, Maron BJ
    Response by Rowin et al to Letter Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
    Circulation. 2018;137:2541-2542.
    PubMed     Text format    


  4. WANG L, Zhao YT
    Letter by Wang and Zhao Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
    Circulation. 2018;137:2540.
    PubMed     Text format    


  5. ZHANG L, Xu XM
    Letter by Zhang and Xu Regarding Article, "Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy".
    Circulation. 2018;137:2539.
    PubMed     Text format    


    May 2018
  6. PACKER M, Kowey PR
    Building Castles in the Sky: Catheter Ablation in Patients With Atrial Fibrillation and Chronic Heart Failure.
    Circulation. 2018 May 30. pii: CIRCULATIONAHA.118.034583.
    PubMed     Text format     Abstract available


  7. YAO C, Veleva T, Scott L Jr, Cao S, et al
    Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation.
    Circulation. 2018 May 25. pii: CIRCULATIONAHA.118.035202.
    PubMed     Text format     Abstract available


  8. NAZHA B, Pandya B, Cohen J, Zhang M, et al
    Periprocedural Outcomes of Direct Oral Anticoagulants vs. Warfarin in Non-Valvular Atrial Fibrillation: A Meta-analysis of Phase III Trials.
    Circulation. 2018 May 24. pii: CIRCULATIONAHA.117.031457.
    PubMed     Text format     Abstract available


  9. HALCOX JPJ, Wareham K
    Response by Halcox and Wareham to Letter Regarding Article, "Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study".
    Circulation. 2018;137:2193-2194.
    PubMed     Text format    


  10. KOSHY AN, Sajeev JK, Teh AW
    Letter by Koshy et al Regarding Article, "Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study".
    Circulation. 2018;137:2191-2192.
    PubMed     Text format    


  11. ELMING MB, Signorovitch J, Kober L, Thune JJ, et al
    Response by Elming et al to Letter Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure".
    Circulation. 2018;137:2190.
    PubMed     Text format    


  12. ADABAG S, Wininger M, Singh SN
    Letter by Adabag et al Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure".
    Circulation. 2018;137:2188-2189.
    PubMed     Text format    


  13. MAGNUSSEN C, Ojeda FM, Schnabel RB
    Response by Magnussen et al to Letter Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk
    Circulation. 2018;137:2087-2088.
    PubMed     Text format    


  14. WANG Y
    Letter by Wang Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe)"
    Circulation. 2018;137:2085-2086.
    PubMed     Text format    


  15. EL-BATTRAWY I, Borggrefe M, Akin I
    Letter by El-Battrawy et al Regarding Article, "Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessmen
    Circulation. 2018;137:2083-2084.
    PubMed     Text format    


  16. KANAGASUNDRAM AN, John RM, Stevenson WG
    Ventricular Tachycardia Ablation in Patients With Implantable Cardioverter Defibrillators Should No Longer Be a Therapy of Last Resort.
    Circulation. 2018;137:1885-1887.
    PubMed     Text format    


    April 2018
  17. O'BRIEN EC, Holmes DN, Thomas LE, Fonarow GC, et al
    Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients with Atrial Fibrillation.
    Circulation. 2018 Apr 20. pii: CIRCULATIONAHA.117.031354.
    PubMed     Text format     Abstract available


  18. CHEN LY, Chung MK, Allen LA, Ezekowitz M, et al
    Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Apr 16. pii: CIR.0000000000000568.
    PubMed     Text format     Abstract available


  19. LAU DH, Nattel S, Kalman JM, Sanders P, et al
    Response by Lau et al to Letters Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation".
    Circulation. 2018;137:1534-1535.
    PubMed     Text format    


  20. BORGHI C, Cicero AFG
    Letter by Borghi and Cicero Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation".
    Circulation. 2018;137:1532-1533.
    PubMed     Text format    


  21. ZEI PC
    Letter by Zei Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation".
    Circulation. 2018;137:1530-1531.
    PubMed     Text format    


  22. SPARTALIS M, Tzatzaki E, Spartalis E
    Letter by Spartalis et al Regarding Article, "Modifiable Risk Factors and Atrial Fibrillation".
    Circulation. 2018;137:1528-1529.
    PubMed     Text format    


    March 2018
  23. JAMES S
    Non-Vitamin K Antagonist Preferred in Patients With Nonvalvular Atrial Fibrillation and Indication for Aspirin Therapy.
    Circulation. 2018;137:1130-1131.
    PubMed     Text format    


  24. JAAKKOLA J, Jaakkola S, Lahdenoja O, Hurnanen T, et al
    Mobile Phone Detection of Atrial Fibrillation With Mechanocardiography: The MODE-AF Study (Mobile Phone Detection of Atrial Fibrillation).
    Circulation. 2018 Mar 11. pii: CIRCULATIONAHA.117.032804.
    PubMed     Text format     Abstract available


    February 2018
  25. CHAO TF, Liu CJ, Lin YJ, Chang SL, et al
    Oral Anticoagulation in Very Elderly Patients with Atrial Fibrillation - A Nationwide Cohort Study.
    Circulation. 2018 Feb 28. pii: CIRCULATIONAHA.117.031658.
    PubMed     Text format     Abstract available


  26. FRIEDMAN DJ, Parzynski CS, Heist EK, Russo AM, et al
    Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: A Report from the National Cardiovascular Data Registry.
    Circulation. 2018 Feb 20. pii: CIRCULATIONAHA.117.032167.
    PubMed     Text format     Abstract available


  27. NIELSEN PB, Skjoth F, Overvad TF, Larsen TB, et al
    Female Sex Is a Risk Modifier Rather Than a Risk Factor for Stroke in Atrial Fibrillation: Should We Use a CHA2DS2-VA Score Rather Than CHA2DS2-VASc?
    Circulation. 2018;137:832-840.
    PubMed     Text format     Abstract available


  28. BEACH LY, Goldschlager N, Moss JD, Scheinman MM, et al
    Response by Beach et al to Letter Regarding Article, "Idiopathic Ventricular Fibrillation in a 29-Year-Old Man".
    Circulation. 2018;137:645.
    PubMed     Text format    


  29. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Idiopathic Ventricular Fibrillation in a 29-Year-Old Man".
    Circulation. 2018;137:643-644.
    PubMed     Text format    


  30. GIUDICESSI JR, Roden DM, Wilde AAM, Ackerman MJ, et al
    Classification and Reporting of Potentially Proarrhythmic Common Genetic Variation in Long QT Syndrome Genetic Testing.
    Circulation. 2018;137:619-630.
    PubMed     Text format     Abstract available


    January 2018
  31. REDDY YNV, Obokata M, Gersh BJ, Borlaug BA, et al
    High Prevalence of Occult Heart Failure With Preserved Ejection Fraction Among Patients With Atrial Fibrillation and Dyspnea.
    Circulation. 2018;137:534-535.
    PubMed     Text format    


  32. GOLD MR
    Treatment of Subclinical Atrial Fibrillation: Does One Plus One Always Equal Two?
    Circulation. 2018;137:217-218.
    PubMed     Text format    


    December 2017
  33. MAHIDA S, Sacher F, Dubois R, Sermesant M, et al
    Cardiac Imaging in Patients With Ventricular Tachycardia.
    Circulation. 2017;136:2491-2507.
    PubMed     Text format     Abstract available


  34. SPIRITO P
    Atrial Fibrillation in Hypertrophic Cardiomyopathy: New Light on an Old Problem.
    Circulation. 2017;136:2437-2439.
    PubMed     Text format    


    November 2017
  35. SELMER C, Faber J
    Mild Thyroid Dysfunction: A Potential Target in Prevention of Atrial Fibrillation?
    Circulation. 2017;136:2117-2118.
    PubMed     Text format    


  36. CALKINS H, Corrado D, Marcus F
    Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.
    Circulation. 2017;136:2068-2082.
    PubMed     Text format     Abstract available


  37. WENG LC, Preis SR, Hulme OL, Larson MG, et al
    Genetic Predisposition, Clinical Risk Factor Burden, and Lifetime Risk of Atrial Fibrillation.
    Circulation. 2017 Nov 12. pii: CIRCULATIONAHA.117.031431.
    PubMed     Text format     Abstract available


  38. AL-KHATIB SM, Pokorney SD
    Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: Diminishing Returns With Advancing Age?
    Circulation. 2017;136:1781-1783.
    PubMed     Text format    


  39. SANDAU KE, Funk M, Auerbach A, Barsness GW, et al
    Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association.
    Circulation. 2017;136:e273-e344.
    PubMed     Text format     Abstract available


  40. BENNAGHMOUCH N, de Veer AJWM, Bode K, Mahmoodi BK, et al
    The Efficacy and Safety of the Use of Non-Vitamin-K Antagonist Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation and Concomitant Aspirin Therapy: A Meta-Analysis of Randomized Trials.
    Circulation. 2017 Nov 3. pii: CIRCULATIONAHA.117.028513.
    PubMed     Text format     Abstract available


  41. MANDALENAKIS Z, Rosengren A, Lappas G, Eriksson P, et al
    Atrial Fibrillation Burden in Young Patients with Congenital Heart Disease.
    Circulation. 2017 Nov 1. pii: CIRCULATIONAHA.117.029590.
    PubMed     Text format     Abstract available


    October 2017
  42. AL-KHATIB SM, Stevenson WG, Ackerman MJ, Bryant WJ, et al
    2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice
    Circulation. 2017 Oct 30. pii: CIR.0000000000000548.
    PubMed     Text format    


  43. KUSUMOTO FM, Bailey KR, Chaouki AS, Deshmukh AJ, et al
    Systematic Review for the 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical P
    Circulation. 2017 Oct 30. pii: CIR.0000000000000550.
    PubMed     Text format    


  44. AL-KHATIB SM, Stevenson WG, Ackerman MJ, Bryant WJ, et al
    2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the
    Circulation. 2017 Oct 30. pii: CIR.0000000000000549.
    PubMed     Text format    


  45. BAUMGARTNER C, da Costa BR, Collet TH, Feller M, et al
    Thyroid Function Within the Normal Range, Subclinical Hypothyroidism and the Risk of Atrial Fibrillation.
    Circulation. 2017 Oct 23. pii: CIRCULATIONAHA.117.028753.
    PubMed     Text format     Abstract available


  46. BAREFIELD DY, Puckelwartz MJ, Kim EY, Wilsbacher LD, et al
    Experimental Modeling Supports a Role for MyBP-HL as a Novel Myofilament Component in Arrhythmia and Dilated Cardiomyopathy.
    Circulation. 2017;136:1477-1491.
    PubMed     Text format     Abstract available


  47. MAGNUSSEN C, Niiranen TJ, Ojeda F, Gianfagna F, et al
    Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).
    Circulation. 2017 Oct 16. pii: CIRCULATIONAHA.117.028981.
    PubMed     Text format     Abstract available


  48. CHO JH, Zhang R, Kilfoil PJ, Gallet R, et al
    Delayed Repolarization Underlies Ventricular Arrhythmias in Rats with Heart Failure and Preserved Ejection Fraction.
    Circulation. 2017 Oct 3. pii: CIRCULATIONAHA.117.028202.
    PubMed     Text format     Abstract available


  49. WIJESURENDRA RS, Casadei B
    Seek and Ye Shall Find Subclinical Atrial Fibrillation in High-Risk Elderly Patients.
    Circulation. 2017;136:1284-1287.
    PubMed     Text format    


    September 2017
  50. BOHULA EA, Wiviott SD, Giugliano RP, Blazing MA, et al
    Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients with Acute Coronary Syndrome in IMPROVE-IT.
    Circulation. 2017 Sep 30. pii: CIRCULATIONAHA.117.029095.
    PubMed     Text format     Abstract available


  51. PARKASH R, Sapp JL, Healey JS, Tang ASL, et al
    Response by Parkash et al to Letters Regarding Article, "Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggres
    Circulation. 2017;136:1271-1272.
    PubMed     Text format    


  52. JIN-SHAN H, Xue-Bin L
    Letter by Jin-shan and Xue-bin Regarding Article, "Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive B
    Circulation. 2017;136:1269-1270.
    PubMed     Text format    


  53. KOSIUK J, Linz D, Hindricks G
    Letter by Kosiuk et al Regarding Article, "Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pre
    Circulation. 2017;136:1267-1268.
    PubMed     Text format    


  54. YE Z, Su Q, Li L
    Letter by Ye et al Regarding Article, "Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open Label Clinical Trial (SMAC-AF [Substrate Modification with Aggressive Blood Pressur
    Circulation. 2017;136:1265-1266.
    PubMed     Text format    


  55. KAPUR S, Barbhaiya C, Deneke T, Michaud GF, et al
    Esophageal Injury and Atrioesophageal Fistula Caused by Ablation for Atrial Fibrillation.
    Circulation. 2017;136:1247-1255.
    PubMed     Text format     Abstract available


  56. ROWIN EJ, Hausvater A, Link MS, Abt P, et al
    Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2017 Sep 15. pii: CIRCULATIONAHA.117.029267.
    PubMed     Text format     Abstract available


  57. KUDENCHUK PJ, Leroux BG, Daya M, Rea T, et al
    Antiarrhythmic Drugs for Non-Shockable-Turned-Shockable Out-of-Hospital Cardiac Arrest: The Amiodarone, Lidocaine or Placebo Study (ALPS).
    Circulation. 2017 Sep 13. pii: CIRCULATIONAHA.117.028624.
    PubMed     Text format     Abstract available


  58. AUFFRET V, Puri R, Urena M, Chamandi C, et al
    Conduction Disturbances After Transcatheter Aortic Valve Replacement: Current Status and Future Perspectives.
    Circulation. 2017;136:1049-1069.
    PubMed     Text format     Abstract available


  59. ELMING MB, Nielsen JC, Haarbo J, Videbaek L, et al
    Age and Outcomes of Primary Prevention Implantable Cardioverter Defibrillators in Patients with Non-Ischemic Systolic Heart Failure.
    Circulation. 2017 Sep 6. pii: CIRCULATIONAHA.117.028829.
    PubMed     Text format     Abstract available


    August 2017
  60. WALDO AL, Camm AJ
    Atrial Fibrillation: Atrial High-Rate Events (AHRES): Look and You Will Find-Then What?
    Circulation. 2017 Aug 28. pii: CIRCULATIONAHA.117.030705.
    PubMed     Text format     Abstract available


  61. HALCOX JPJ, Wareham K, Cardew A, Gilmore M, et al
    Assessment of Remote Heart Rhythm Sampling Using the AliveCor Heart Monitor to Screen for Atrial Fibrillation: The REHEARSE-AF Study.
    Circulation. 2017 Aug 28. pii: CIRCULATIONAHA.117.030583.
    PubMed     Text format     Abstract available


  62. LAU DH, Nattel S, Kalman JM, Sanders P, et al
    Modifiable Risk Factors and Atrial Fibrillation.
    Circulation. 2017;136:583-596.
    PubMed     Text format     Abstract available


  63. HEALEY JS, Alings M, Ha AC, Leong-Sit P, et al
    Subclinical Atrial Fibrillation in Older Patients.
    Circulation. 2017 Aug 4. pii: CIRCULATIONAHA.117.028845.
    PubMed     Text format     Abstract available


  64. KALMAN JM, Sanders P, Rosso R, Calkins H, et al
    Should We Perform Catheter Ablation for Asymptomatic Atrial Fibrillation?
    Circulation. 2017;136:490-499.
    PubMed     Text format     Abstract available


    July 2017
  65. CHATTERJEE NA, Chasman DI, Albert CM
    Response by Chatterjee et al to Letter Regarding Article, "Genetic Obesity and the Risk of Atrial Fibrillation: Causal Estimates From Mendelian Randomization".
    Circulation. 2017;136:434-435.
    PubMed     Text format    


  66. KON KOH K
    Letter by Koh Regarding Article, "Genetic Obesity and the Risk of Atrial Fibrillation: Causal Estimates from Mendelian Randomization".
    Circulation. 2017;136:432-433.
    PubMed     Text format    


  67. GIBSON CM, Fox K
    Response by Gibson and Fox to Letter Regarding Article, "Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonis
    Circulation. 2017;136:117.
    PubMed     Text format    


  68. CERIT L
    Letter by Cerit Regarding Article, "Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy"
    Circulation. 2017;136:115-116.
    PubMed     Text format    


  69. BEACH LY, Goldschlager N, Moss JD, Scheinman MM, et al
    Idiopathic Ventricular Fibrillation in a 29-Year-Old Man.
    Circulation. 2017;136:112-114.
    PubMed     Text format    


    June 2017
  70. GOLWALA H, Bajaj NS, Arora G, Arora P, et al
    Response by Golwala et al to Letter Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".
    Circulation. 2017;135:e1200-e1202.
    PubMed     Text format    


  71. NERY PB, Lewis KB, Birnie DH
    Letter by Nery et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".
    Circulation. 2017;135:e1198-e1199.
    PubMed     Text format    


  72. BARAKAT AF, Saad M, Elgendy IY
    Letter by Barakat et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".
    Circulation. 2017;135:e1196-e1197.
    PubMed     Text format    


  73. LAMPERT R, Olshansky B, Heidbuchel H, Lawless C, et al
    Safety of Sports for Athletes With Implantable Cardioverter-Defibrillators: Long-Term Results of a Prospective Multinational Registry.
    Circulation. 2017;135:2310-2312.
    PubMed     Text format    


  74. COYLEWRIGHT M, Holmes DR Jr
    Caution Regarding Government-Mandated Shared Decision Making for Patients With Atrial Fibrillation.
    Circulation. 2017;135:2211-2213.
    PubMed     Text format    


  75. YAMAGATA K, Horie M, Aiba T, Ogawa S, et al
    Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter Registry.
    Circulation. 2017;135:2255-2270.
    PubMed     Text format     Abstract available


    May 2017
  76. FREEDMAN B, Camm J, Calkins H, Healey JS, et al
    Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration.
    Circulation. 2017;135:1851-1867.
    PubMed     Text format     Abstract available


  77. LAU DH, Hendriks J, Kalman JM, Sanders P, et al
    Blood Pressure Control in Atrial Fibrillation: One of Many Critical Components in Risk Factor Modification.
    Circulation. 2017;135:1799-1801.
    PubMed     Text format    



  78. Correction to: Severe Pulmonary Vein Stenosis Resulting From Ablation for Atrial Fibrillation: Presentation, Management, and Clinical Outcomes.
    Circulation. 2017;135:e1016.
    PubMed     Text format    


  79. FENDER EA, Widmer RJ, Holmes DR Jr, Packer DL, et al
    Response by Fender et al to Letter Regarding Article, "Severe Pulmonary Vein Stenosis Resulting From Ablation for Atrial Fibrillation: Presentation, Management, and Clinical Outcomes".
    Circulation. 2017;135:e1014-e1015.
    PubMed     Text format    


  80. JAZAYERI MA, Reddy YM, Lakkireddy DR
    Letter by Jazayeri et al Regarding Article, "Severe Pulmonary Vein Stenosis Resulting From Ablation for Atrial Fibrillation: Presentation, Management, and Clinical Outcomes".
    Circulation. 2017;135:e1012-e1013.
    PubMed     Text format    


    April 2017
  81. FLYER JN, Zuckerman WA, Richmond ME, Anderson BR, et al
    Prospective Study of Adenosine on Atrioventricular Nodal Conduction in Pediatric and Young Adult Patients After Heart Transplant.
    Circulation. 2017 Apr 27. pii: CIRCULATIONAHA.117.028087.
    PubMed     Text format     Abstract available


  82. VERMA A, Kalman JM, Callans DJ
    Treatment of Patients With Atrial Fibrillation and Heart Failure With Reduced Ejection Fraction.
    Circulation. 2017;135:1547-1563.
    PubMed     Text format     Abstract available


  83. TJONG FV, Reddy VY
    Permanent Leadless Cardiac Pacemaker Therapy: A Comprehensive Review.
    Circulation. 2017;135:1458-1470.
    PubMed     Text format     Abstract available


  84. STRAUSS DG, Vicente J, Johannesen L, Blinova K, et al
    Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.
    Circulation. 2017;135:1300-1310.
    PubMed     Text format     Abstract available


    March 2017
  85. SCHEINMAN MA, Rutherford JD
    The Development of Cardiac Arrhythmia Ablation: A Conversation With Melvin A. Scheinman, MD.
    Circulation. 2017;135:1191-1193.
    PubMed     Text format     Abstract available



  86. Correction to: Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.
    Circulation. 2017;135:e789.
    PubMed     Text format    


  87. SISCOVICK DS, Barringer TA, Fretts AM, Wu JH, et al
    Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Circulation. 2017 Mar 13. pii: CIR.0000000000000482.
    PubMed     Text format     Abstract available


  88. LINDNER SM, Fordyce CB, Hellkamp AS, Lokhnygina Y, et al
    Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atria
    Circulation. 2017;135:1001-1003.
    PubMed     Text format    


  89. RAVAL AN, Cigarroa JE, Chung MK, Diaz-Sandoval LJ, et al
    Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.
    Circulation. 2017;135:e604-e633.
    PubMed     Text format     Abstract available


    February 2017
  90. WHITMAN IR, Gladstone RA, Badhwar N, Hsia HH, et al
    Brain Emboli After Left Ventricular Endocardial Ablation.
    Circulation. 2017;135:867-877.
    PubMed     Text format     Abstract available


  91. HYLTEN-CAVALLIUS L, Iepsen EW, Wewer Albrechtsen NJ, Svendstrup M, et al
    Patients with Long QT Syndrome Due to Impaired hERG-encoded Kv11.1 Potassium Channel Have Exaggerated Endocrine Pancreatic and Incretin Function Associated with Reactive Hypoglycemia.
    Circulation. 2017 Feb 24. pii: CIRCULATIONAHA.116.024279.
    PubMed     Text format     Abstract available


  92. PARKASH R, Wells GA, Sapp JL, Healey JS, et al
    The Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open Label, Clinical Trial (Substrate Modification with Aggressive Blood Pressure Control: SMAC- AF).
    Circulation. 2017 Feb 22. pii: CIRCULATIONAHA.116.026230.
    PubMed     Text format     Abstract available



  93. Correction to: Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Circulation. 2017;135:e48.
    PubMed     Text format    


  94. SIONTIS KC, Yao X, Gersh BJ, Noseworthy PA, et al
    Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease Other Than Significant Mitral Stenosis and Mechanical Valves: A Meta-Analysis.
    Circulation. 2017;135:714-716.
    PubMed     Text format    


  95. CHOWDHURY SK, Liu W, Zi M, Li Y, et al
    Stress-Activated Kinase Mitogen-Activated Kinase Kinase-7 Governs Epigenetics of Cardiac Repolarization for Arrhythmia Prevention.
    Circulation. 2017;135:683-699.
    PubMed     Text format     Abstract available


  96. WONG JA, Rexrode KM, Sandhu RK, Conen D, et al
    Number of Pregnancies and Atrial Fibrillation Risk: The Women's Health Study.
    Circulation. 2017;135:622-624.
    PubMed     Text format    


  97. GILLIS AM
    Atrial Fibrillation and Ventricular Arrhythmias: Sex Differences in Electrophysiology, Epidemiology, Clinical Presentation, and Clinical Outcomes.
    Circulation. 2017;135:593-608.
    PubMed     Text format     Abstract available


  98. RAO MP, Al-Khatib SM, Pokorney S, She L, et al
    Sudden Cardiac Death in Patients with Ischemic Heart Failure Undergoing Coronary Artery Bypass Grafting: Results from the Surgical Treatment for Ischemic Heart Failure (STICH) Randomized Clinical Trial.
    Circulation. 2017 Feb 2. pii: CIRCULATIONAHA.116.026075.
    PubMed     Text format     Abstract available


  99. FREEMAN JV, Wang Y, Akar JG, Desai N, et al
    National Trends in Atrial Fibrillation Hospitalization, Readmission,and Mortality for Medicare Beneficiaries, 1999-2013.
    Circulation. 2017 Feb 1. pii: CIRCULATIONAHA.116.022388.
    PubMed     Text format     Abstract available


    January 2017
  100. HESS PL, Hernandez AF, Bhatt DL, Hellkamp AS, et al
    Response by Hess et al to Letter Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failur
    Circulation. 2017;135:e22-e23.
    PubMed     Text format    


  101. DHRUVA SS, Redberg RF
    Letter by Dhruva and Redberg Regarding Article, "Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings From the Get With The Guidelines-Heart Failure Pr
    Circulation. 2017;135:e20-e21.
    PubMed     Text format    


  102. NIELSEN PB, Lip GY
    Adding Rigor to Stroke Rate Investigations in Patients With Atrial Fibrillation.
    Circulation. 2017;135:220-223.
    PubMed     Text format    


  103. LINK MS, Haissaguerre M, Natale A
    Response by Link et al to Letter Regarding Article, "Ablation of Atrial Fibrillation: Patient Selection, Periprocedural Anticoagulation, Techniques, and Preventive Measures After Ablation".
    Circulation. 2017;135:e3-e4.
    PubMed     Text format    


  104. MAESEN B, Pison L, Meir M
    Letter by Maesen et al Regarding Article, "Ablation of Atrial Fibrillation: Patient Selection, Periprocedural Anticoagulation, Techniques, and Preventive Measures After Ablation".
    Circulation. 2017;135:e1-e2.
    PubMed     Text format    


  105. CHAN PH, Wong CK, Pun L, Wong YF, et al
    Head-to-Head Comparison of the AliveCor Heart Monitor and Microlife WatchBP Office AFIB for Atrial Fibrillation Screening in a Primary Care Setting.
    Circulation. 2017;135:110-112.
    PubMed     Text format    


  106. HAMPTON T
    Handheld Technologies May Lead to Better Detection of Atrial Fibrillation.
    Circulation. 2017;135:108-109.
    PubMed     Text format    


  107. LA GERCHE A, Brosnan MJ
    Cardiovascular Effects of Performance-Enhancing Drugs.
    Circulation. 2017;135:89-99.
    PubMed     Text format     Abstract available


    December 2016
  108. WIBERG S, Hassager C, Schmidt H, Thomsen JH, et al
    Neuroprotective Effects of the Glucagon-Like Peptide-1 Analog Exenatide After Out-of-Hospital Cardiac Arrest: A Randomized Controlled Trial.
    Circulation. 2016;134:2115-2124.
    PubMed     Text format     Abstract available


  109. GOTO Y, Funada A, Goto Y
    Duration of Prehospital Cardiopulmonary Resuscitation and Favorable Neurological Outcomes for Pediatric Out-of-Hospital Cardiac Arrests: A Nationwide, Population-Based Cohort Study.
    Circulation. 2016;134:2046-2059.
    PubMed     Text format     Abstract available


  110. GOLWALA H, Bajaj NS, Arora G, Arora P, et al
    Implantable Cardioverter-Defibrillator for Non Ischemic Cardiomyopathy: An Updated Meta-Analysis.
    Circulation. 2016 Dec 19. pii: CIRCULATIONAHA.116.026056.
    PubMed     Text format     Abstract available


  111. CHATTERJEE NA, Giulianini F, Geelhoed B, Lunetta KL, et al
    Genetic Obesity and the Risk of Atrial Fibrillation- Causal Estimates from Mendelian Randomization.
    Circulation. 2016 Dec 14. pii: CIRCULATIONAHA.116.024921.
    PubMed     Text format     Abstract available


  112. LI N, Hansen BJ, Fedorov VV
    Response by Li et al to Letter Regarding Article, "Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria Due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human Heart".
    Circulation. 2016;134:e648-e649.
    PubMed     Text format    


  113. HE YM
    Letter by He Regarding Article, "Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria Due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human Heart".
    Circulation. 2016;134:e647.
    PubMed     Text format    


    November 2016
  114. MELDUNI RM, Schaff HV, Lee HC, Gersh BJ, et al
    Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score Matched Analysis of 10,633 Patients.
    Circulation. 2016 Nov 30. pii: CIRCULATIONAHA.116.021952.
    PubMed     Text format     Abstract available


  115. POKORNEY SD, Miller AL, Chen AY, Thomas L, et al
    Reassessment of Cardiac Function and Implantable Cardioverter-Defibrillator Use Among Medicare Patients with Low Ejection Fraction After Myocardial Infarction.
    Circulation. 2016 Nov 16. pii: CIRCULATIONAHA.116.022359.
    PubMed     Text format     Abstract available


  116. GIBSON CM, Pinto DS, Chi G, Arbetter D, et al
    Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.
    Circulation. 2016 Nov 14. pii: CIRCULATIONAHA.116.025783.
    PubMed     Text format     Abstract available


  117. HALPERIN JL, Savino JA 3rd
    Response by Halperin and Savino to Letter Regarding Article, "Should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? The CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower End
    Circulation. 2016;134:e391-e392.
    PubMed     Text format    


  118. NIELSEN PB, Lip GY
    Response by Nielsen and Lip to Letter Regarding Article, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke".
    Circulation. 2016;134:e389-e390.
    PubMed     Text format    


  119. ASINGER RW, Shroff GR, Herzog CA
    Letter by Asinger et al Regarding Articles, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" and "Should Patie
    Circulation. 2016;134:e387-e388.
    PubMed     Text format    


  120. AL-KHATIB SM, Friedman P, Ellenbogen KA
    Defibrillators: Selecting the Right Device for the Right Patient.
    Circulation. 2016;134:1390-1404.
    PubMed     Text format     Abstract available


    October 2016
  121. QUINN GR, Severdija ON, Chang Y, Singer DE, et al
    Wide Variation in Reported Rates of Stroke Across Cohorts of Patients with Atrial Fibrillation.
    Circulation. 2016 Oct 31. pii: CIRCULATIONAHA.116.024057.
    PubMed     Text format     Abstract available


  122. LUBITZ SA, Yin X, Lin H, Kolek M, et al
    Genetic Risk Prediction of Atrial Fibrillation.
    Circulation. 2016 Oct 28. pii: CIRCULATIONAHA.116.024143.
    PubMed     Text format     Abstract available


  123. FENDER EA, Widmer RJ, Hodge DO, Cooper GM, et al
    Severe Pulmonary Vein Stenosis Resulting from Ablation for Atrial Fibrillation: Presentation, Management and Clinical Outcomes.
    Circulation. 2016 Oct 28. pii: CIRCULATIONAHA.116.021949.
    PubMed     Text format     Abstract available


  124. SWIRYN S, Orlov MV, Benditt DG, DiMarco JP, et al
    Clinical Implications of Brief Device-Detected Atrial Tachyarrhythmias in a Cardiac Rhythm Management Device Population: Results from the Registry of Atrial Tachycardia and Atrial Fibrillation Episodes.
    Circulation. 2016;134:1130-1140.
    PubMed     Text format     Abstract available


  125. KATRITSIS DG, Marine JE, Contreras FM, Fujii A, et al
    Catheter Ablation of Atypical Atrioventricular Nodal Reentrant Tachycardia.
    Circulation. 2016 Oct 17. pii: CIRCULATIONAHA.116.024471.
    PubMed     Text format     Abstract available


    September 2016
  126. WIJESURENDRA RS, Liu A, Eichhorn C, Ariga R, et al
    "Lone" Atrial Fibrillation Is Associated With Impaired Left Ventricular Energetics That Persist Despite Successful Catheter Ablation.
    Circulation. 2016 Sep 14. pii: CIRCULATIONAHA.116.022931.
    PubMed     Text format     Abstract available


  127. HYMAN MC, Callans DJ
    Mental Exit Block: Escaping the Pulmonary Veins in Search of New Approaches to Atrial Fibrillation Management.
    Circulation. 2016 Sep 14. pii: CIRCULATIONAHA.116.024636.
    PubMed     Text format     Abstract available


  128. CHAO TF, Liu CJ, Liao JN, Wang KL, et al
    Response by Chao et al to Letters Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e230-1.
    PubMed     Text format    


  129. YANG X, An R, Xu Y
    Letter by Yang et al Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e228-9.
    PubMed     Text format    


  130. CHAN PH, Siu CW
    Letter by Chan and Siu Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e226-7.
    PubMed     Text format    


  131. DI BIASE L, Mohanty P, Mohanty S, Santangeli P, et al
    Response by Di Biase et al to Letter Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial"
    Circulation. 2016;134:e189-90.
    PubMed     Text format    


  132. SKOLNIK N
    Letter from Skolnik Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
    Circulation. 2016;134:e187-8.
    PubMed     Text format    


  133. LIU W, Yang XJ
    Letter from Liu and Yang Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
    Circulation. 2016;134:e185-6.
    PubMed     Text format    


  134. KOSIUK J, Hindricks G, Bollmann A
    Letter from Kosiuk et al Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
    Circulation. 2016;134:e183-4.
    PubMed     Text format    


  135. WILLEY JZ, Biviano A
    Letter from Willey and Biviano Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
    Circulation. 2016;134:e181-2.
    PubMed     Text format    


  136. TURCO P
    Letter from Turco Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial".
    Circulation. 2016;134:e179-80.
    PubMed     Text format    


    August 2016
  137. WASSNIG NK, Gunther M, Quick S, Pfluecke C, et al
    Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death.
    Circulation. 2016;134:635-43.
    PubMed     Text format     Abstract available


  138. OLDGREN J, Hijazi Z, Lindback J, Alexander JH, et al
    Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.
    Circulation. 2016 Aug 28. pii: CIRCULATIONAHA.116.022802.
    PubMed     Text format     Abstract available


  139. WILDE AA, Moss AJ, Kaufman ES, Shimizu W, et al
    Clinical Aspects of Type 3 Long QT Syndrome: An International Multicenter Study.
    Circulation. 2016 Aug 26. pii: CIRCULATIONAHA.116.021823.
    PubMed     Text format     Abstract available


  140. BARALLOBRE-BARREIRO J, Gupta SK, Zoccarato A, Kitazume-Taneike R, et al
    Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation.
    Circulation. 2016 Aug 24. pii: CIRCULATIONAHA.115.016423.
    PubMed     Text format     Abstract available


  141. NORBY FL, Soliman EZ, Chen LY, Bengtson LG, et al
    Trajectories of Cardiovascular Risk Factors and Incidence of Atrial Fibrillation Over a 25-Year Follow-Up: The ARIC Study (Atherosclerosis Risk in Communities).
    Circulation. 2016;134:599-610.
    PubMed     Text format     Abstract available


  142. SHARKEY SW, Orlandi Q, Olivari MT
    Response by Sharkey et al to Letter Regarding Article, "Giant J Waves and ST-Segment Elevation Associated With Acute Gastric Distension".
    Circulation. 2016;134:e111-2.
    PubMed     Text format    


  143. LITTMANN L
    Letter by Littmann Regarding Article, "Giant J Waves and ST-Segment Elevation Associated With Acute Gastric Distension".
    Circulation. 2016;134:e109-10.
    PubMed     Text format    


  144. REIFFEL JA
    ECG Response: Can You Make The Correct Morphology, Pathology, and Rhythm Diagnoses?
    Circulation. 2016;134:567-9.
    PubMed     Text format    


  145. EZEKOWITZ MD, Nagarakanti R, Noack H, Brueckmann M, et al
    Comparison of Dabigatran versus Warfarin in Patients with Atrial Fibrillation and Valvular Heart Disease: The RE-LY Trial.
    Circulation. 2016 Aug 5. pii: CIRCULATIONAHA.115.020950.
    PubMed     Text format     Abstract available


  146. HESS PL, Hernandez AF, Bhatt DL, Hellkamp AS, et al
    Sex and Race/Ethnicity Differences in Implantable Cardioverter-Defibrillator Counseling and Use Among Patients Hospitalized With Heart Failure: Findings from the Get With The Guidelines-Heart Failure Program.
    Circulation. 2016 Aug 4. pii: CIRCULATIONAHA.115.021048.
    PubMed     Text format     Abstract available


  147. LIP GY
    Response by Lip to Letter Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring".
    Circulation. 2016;134:e30-1.
    PubMed     Text format    


  148. HESS PL, Lopes RD, Healey JS
    Letter by Hess et al Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring".
    Circulation. 2016;134:e28-9.
    PubMed     Text format    


    July 2016
  149. LI N, Csepe TA, Hansen BJ, Sul LV, et al
    Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human Heart.
    Circulation. 2016 Jul 26. pii: CIRCULATIONAHA.115.021165.
    PubMed     Text format     Abstract available


  150. LINK MS, Haissaguerre M, Natale A
    Ablation of Atrial Fibrillation: Patient Selection, Periprocedural Anticoagulation, Techniques, and Preventive Measures After Ablation.
    Circulation. 2016;134:339-52.
    PubMed     Text format     Abstract available


  151. ANTER E, Tschabrunn CM, Buxton AE, Josephson ME, et al
    High-Resolution Mapping of Postinfarction Reentrant Ventricular Tachycardia: Electrophysiological Characterization of the Circuit.
    Circulation. 2016;134:314-27.
    PubMed     Text format     Abstract available


  152. HE VY, Condon JR, Ralph AP, Zhao Y, et al
    Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis Approach.
    Circulation. 2016;134:222-32.
    PubMed     Text format     Abstract available


  153. PICCINI JP, Hellkamp AS, Washam JB, Becker RC, et al
    Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e7-8.
    PubMed     Text format    


  154. IMPRIALOS K, Boutari C, Stavropoulos K
    Letter by Imprialos et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e5-6.
    PubMed     Text format    


  155. BOUATOU Y, El Biali M, Samer CF
    Letter by Bouatou et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e3-4.
    PubMed     Text format    


  156. HIJAZI Z, Wallentin L
    Renal Function in Atrial Fibrillation: A Multifaceted Dilemma.
    Circulation. 2016;134:48-51.
    PubMed     Text format    


  157. FORDYCE CB, Hellkamp AS, Lokhnygina Y, Lindner SM, et al
    On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.
    Circulation. 2016;134:37-47.
    PubMed     Text format     Abstract available


  158. BOHULA EA, Giugliano RP, Ruff CT, Kuder JF, et al
    Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial.
    Circulation. 2016;134:24-36.
    PubMed     Text format     Abstract available


    June 2016
  159. ALBERT CM, Stevenson WG
    The Future of Arrhythmias and Electrophysiology.
    Circulation. 2016;133:2687-96.
    PubMed     Text format    


  160. WILLIS BC, Pandit SV, Ponce-Balbuena D, Zarzoso M, et al
    Constitutive Intracellular Na+ Excess in Purkinje Cells Promotes Arrhythmogenesis at Lower Levels of Stress Than Ventricular Myocytes From Mice With Catecholaminergic Polymorphic Ventricular Tachycardia.
    Circulation. 2016;133:2348-59.
    PubMed     Text format     Abstract available


  161. SANTHANAKRISHNAN R, Wang N, Larson MG, Magnani JW, et al
    Response to Letter Regarding Article, "Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction".
    Circulation. 2016;133:e692-3.
    PubMed     Text format    


  162. PROVIDENCIA R, Lambiase PD
    Letter by Providencia and Lambiase Regarding Article, "Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction".
    Circulation. 2016;133:e691.
    PubMed     Text format    


    May 2016
  163. MACINTYRE C, Lakdawala NK
    Management of Atrial Fibrillation in Hypertrophic Cardiomyopathy.
    Circulation. 2016;133:1901-5.
    PubMed     Text format    


  164. MCMURRAY JJ
    Disease Management Programs in Cardiology: Extending the Success in Failure.
    Circulation. 2016;133:1836-7.
    PubMed     Text format    


  165. JOHN RM, Kumar S
    Sinus Node and Atrial Arrhythmias.
    Circulation. 2016;133:1892-900.
    PubMed     Text format     Abstract available


  166. ALVAREZ-GARCIA J, Vives-Borras M, Gomis P, Ordonez-Llanos J, et al
    Electrophysiological Effects of Selective Atrial Coronary Artery Occlusion in Humans.
    Circulation. 2016 May 5. pii: CIRCULATIONAHA.116.021700.
    PubMed     Text format     Abstract available



  167. ECG Response: May 3, 2016.
    Circulation. 2016;133:1827.
    PubMed     Text format    


    April 2016

  168. ECG Response: April 19, 2016.
    Circulation. 2016;133:1625-6.
    PubMed     Text format    


  169. WAKS JW, Sitlani CM, Soliman EZ, Kabir M, et al
    Global Electrical Heterogeneity Risk Score for Prediction of Sudden Cardiac Death in the General Population: The Atherosclerosis Risk in Communities (ARIC) and Cardiovascular Health (CHS) Studies.
    Circulation. 2016 Apr 14. pii: CIRCULATIONAHA.116.021306.
    PubMed     Text format     Abstract available


  170. KUMAR S, Sparks PB, Kalman JM
    Letter by Kumar et al Regarding Article, "Extensive Intramural Esophageal Hematoma After Transesophageal Echocardiography During Atrial Fibrillation Ablation".
    Circulation. 2016;133:e594.
    PubMed     Text format    


  171. QAMAR A, Bhatt DL
    Stroke Prevention in Atrial Fibrillation in Patients With Chronic Kidney Disease.
    Circulation. 2016;133:1512-5.
    PubMed     Text format    


  172. SAVINO JA 3RD, Halperin JL
    Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? The CHA2 DS2-VASc 1 Conundrum: Decision Making at the Lower End of the Risk Spectrum.
    Circulation. 2016;133:1504-11.
    PubMed     Text format    


  173. LIP GY, Nielsen PB
    Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke.
    Circulation. 2016;133:1498-503.
    PubMed     Text format    


  174. PATTON KK, Ellinor PT, Ezekowitz M, Kowey P, et al
    Electrocardiographic Early Repolarization: A Scientific Statement From the American Heart Association.
    Circulation. 2016;133:1520-9.
    PubMed     Text format    


  175. DE LAZZARI M, Fedrigo M, Migliore F, Cianci A, et al
    Nonamyloidotic Light Chain Cardiomyopathy: The Arrhythmogenic Magnetic Resonance Pattern.
    Circulation. 2016;133:1421-3.
    PubMed     Text format    



  176. ECG Response: April 5, 2016.
    Circulation. 2016;133:1419-20.
    PubMed     Text format    


  177. PAGE RL, Joglar JA, Caldwell MA, Calkins H, et al
    2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
    Circulation. 2016;133:e506-74.
    PubMed     Text format    


  178. PAGE RL, Joglar JA, Caldwell MA, Calkins H, et al
    2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rh
    Circulation. 2016;133:e471-505.
    PubMed     Text format    


  179. AL-KHATIB SM, Arshad A, Balk EM, Das SR, et al
    Risk Stratification for Arrhythmic Events in Patients With Asymptomatic Pre-Excitation: A Systematic Review for the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of
    Circulation. 2016;133:e575-86.
    PubMed     Text format     Abstract available


    March 2016
  180. DI BIASE L, Mohanty P, Mohanty S, Santangeli P, et al
    Ablation vs. Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial.
    Circulation. 2016 Mar 30. pii: CIRCULATIONAHA.115.019406.
    PubMed     Text format     Abstract available


  181. KOPLAN BA, Stevenson WG
    Atrial Fibrillation in Heart Failure: Should Catheter Ablation Play a Larger Role?
    Circulation. 2016 Mar 30. pii: CIRCULATIONAHA.116.022261.
    PubMed     Text format     Abstract available


  182. LIP GY
    How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring.
    Circulation. 2016;133:1290-5.
    PubMed     Text format    


  183. BASSO C, Marra MP, Rizzo S, De Lazzari M, et al
    Response to Letters Regarding Article, "Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death".
    Circulation. 2016;133:e460.
    PubMed     Text format    


  184. PROVIDENCIA R, Lambiase PD
    Letter by Providencia and Lambiase Regarding Article, "Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death".
    Circulation. 2016;133:e459.
    PubMed     Text format    


  185. SHEPPARD MN, Steriotis AK, Sharma S
    Letter by Sheppard et al Regarding Article, "Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death".
    Circulation. 2016;133:e458.
    PubMed     Text format    


  186. KRAMER DB, Reynolds MR, Normand SL, Parzynski CS, et al
    Hospice Use Following Implantable Cardioverter-Defibrillator Implantation in Older Patients: Results From the NCDR(R).
    Circulation. 2016 Mar 25. pii: CIRCULATIONAHA.115.020677.
    PubMed     Text format     Abstract available



  187. ECG Response: March 22, 2016.
    Circulation. 2016;133:1217.
    PubMed     Text format    


  188. ADAY AW, Sobieszczyk PS, Beckman JA
    Absent at Birth: An Unusual Case of Deep Vein Thrombosis.
    Circulation. 2016;133:1209-16.
    PubMed     Text format    


  189. SCHMIDT C, Wiedmann F, Voigt N, Zhou XB, et al
    Response to Letter Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation".
    Circulation. 2016;133:e440-1.
    PubMed     Text format    


  190. OLSCHEWSKI A, Chandran N, Olschewski H
    Letter by Olschewski et al Regarding Article, "Upregulation of K2P3.1 K+ Current Causes Action Potential Shortening in Patients With Chronic Atrial Fibrillation".
    Circulation. 2016;133:e439.
    PubMed     Text format    


  191. CORRADO D, Wichter T, Link MS, Hauer R, et al
    Response to Letter Regarding Article, "Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement".
    Circulation. 2016;133:e437-8.
    PubMed     Text format    


  192. BARISON A, Todiere G, Aquaro GD
    Letter by Barison et al Regarding Article, "Treatment of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: An International Task Force Consensus Statement".
    Circulation. 2016;133:e436.
    PubMed     Text format    


  193. HIBBS J, Orlandi Q, Olivari MT, Dickey W, et al
    Giant J Waves and ST-Segment Elevation Associated With Acute Gastric Distension.
    Circulation. 2016;133:1132-4.
    PubMed     Text format    


  194. CHAO TF, Liu CJ, Liao JN, Wang KL, et al
    The Use of Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Patients with History of Intra-Cranial Hemorrhage.
    Circulation. 2016 Mar 11. pii: CIRCULATIONAHA.115.019794.
    PubMed     Text format     Abstract available


  195. GOLDBERGER JJ, Arora R, Green D, Greenland P, et al
    Response to Letter Regarding Article, "Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate".
    Circulation. 2016;133:e431.
    PubMed     Text format    


  196. JOGIA D, Liang M
    Letter by Jogia and Liang Regarding Article, "Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate".
    Circulation. 2016;133:e430.
    PubMed     Text format    



  197. ECG Response: March 8, 2016.
    Circulation. 2016;133:1047.
    PubMed     Text format    


    February 2016

  198. ECG Response: February 23, 2016.
    Circulation. 2016;133:764.
    PubMed     Text format    


  199. HAEGELI LM, Della Bella P, Brunckhorst CB
    Management of a Patient With Electrical Storm: Role of Epicardial Catheter Ablation.
    Circulation. 2016;133:672-6.
    PubMed     Text format    


  200. SROUBEK J, Probst V, Mazzanti A, Delise P, et al
    Programmed Ventricular Stimulation for Risk Stratification in the Brugada Syndrome: A Pooled Analysis.
    Circulation. 2016;133:622-30.
    PubMed     Text format     Abstract available


  201. DAOUD EG
    Even a Pooled Analysis Does Not Resolve the Debate of Electrophysiology Testing in Brugada Syndrome.
    Circulation. 2016;133:619-21.
    PubMed     Text format    


  202. HONDA S, Kawasaki T, Shiraishi H, Yamano M, et al
    Mitral Valve Prolapse Revisited.
    Circulation. 2016;133:e380-2.
    PubMed     Text format    



  203. ECG Response: February 9, 2016.
    Circulation. 2016;133:610-1.
    PubMed     Text format    


    January 2016
  204. DE FERRARI GM, Dusi V, Spazzolini C, Bos JM, et al
    Response to Letters Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation".
    Circulation. 2016;133:e366-7.
    PubMed     Text format    


  205. GOW RM
    Letter by Gow Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation".
    Circulation. 2016;133:e365.
    PubMed     Text format    


  206. PATANE S
    Letter by Patane Regarding Article, "Clinical Management of Catecholaminergic Polymorphic Ventricular Tachycardia: The Role of Left Cardiac Sympathetic Denervation".
    Circulation. 2016;133:e364.
    PubMed     Text format    



  207. ECG Response: January 26, 2016.
    Circulation. 2016;133:442-3.
    PubMed     Text format    


  208. ELAGHA AA, Weissman G
    Pacemaker Malfunction Attributed to Multidetector Cardiac Computed Tomography.
    Circulation. 2016;133:342-3.
    PubMed     Text format    


  209. PADFIELD GJ, Escudero CA, De Souza AM, Steinberg C, et al
    Characterization of Myocardial Repolarization Reserve in Adolescent Females with Anorexia Nervosa.
    Circulation. 2016 Jan 14. pii: CIRCULATIONAHA.115.016697.
    PubMed     Text format     Abstract available



  210. ECG Response: January 12, 2016.
    Circulation. 2016;133:232-3.
    PubMed     Text format    


  211. SANTHANAKRISHNAN R, Wang N, Larson MG, Magnani JW, et al
    Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved vs. Reduced Ejection Fraction.
    Circulation. 2016 Jan 8. pii: CIRCULATIONAHA.115.018614.
    PubMed     Text format     Abstract available


  212. OLEN MM, Baysa SJ, Rossi A, Kanter RJ, et al
    Wolff-Parkinson-White Syndrome: A Stepwise Deterioration to Sudden Death.
    Circulation. 2016;133:105-6.
    PubMed     Text format    


  213. MALMO V, Nes BM, Amundsen BH, Tjonna AE, et al
    Aerobic Interval Training Reduces the Burden of Atrial Fibrillation in the Short Term: A Randomized Trial.
    Circulation. 2016 Jan 5. pii: CIRCULATIONAHA.115.018220.
    PubMed     Text format     Abstract available


  214. ELLIOTT AD, Mahajan R, Pathak RK, Lau DH, et al
    Exercise Training and Atrial Fibrillation: Further Evidence for the Importance of Lifestyle Change.
    Circulation. 2016 Jan 5. pii: CIRCULATIONAHA.115.020800.
    PubMed     Text format     Abstract available


    December 2015
  215. QURESHI WT, Alirhayim Z, Blaha MJ, Juraschek SP, et al
    Response to Letter Regarding Article, "Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation: Results From the Henry Ford Exercise Testing (FIT) Project".
    Circulation. 2015;132:e395.
    PubMed     Text format    


  216. PATANE S
    Letter by Patane Regarding Article, "Cardiorespiratory Fitness and Risk of Incident Atrial Fibrillation: Results From the Henry Ford Exercise Testing (FIT) Project".
    Circulation. 2015;132:e394.
    PubMed     Text format    


  217. SARDANA M
    Letter by Sardana Regarding Article, "Long-Term Outcomes of Secondary Atrial Fibrillation in the Community: The Framingham Heart Study".
    Circulation. 2015;132:e393.
    PubMed     Text format    


  218. PATEL MR, Piccini JP
    The Need to Evaluate Net Clinical Effect of Stroke Prevention Therapy in Patients with End Stage Renal Disease and Atrial Fibrillation.
    Circulation. 2015 Dec 17. pii: CIRCULATIONAHA.115.020378.
    PubMed     Text format     Abstract available


  219. SHIH CJ, Ou SM, Chao PW, Kuo SC, et al
    Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation: A Competing-Risk Analysis of a Nationwide Cohort.
    Circulation. 2015 Dec 17. pii: CIRCULATIONAHA.115.018294.
    PubMed     Text format     Abstract available


  220. PICCINI JP, Hellkamp AS, Washam JB, Becker RC, et al
    Polypharmacy and the Efficacy and Safety of Rivaroxaban versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation.
    Circulation. 2015 Dec 16. pii: CIRCULATIONAHA.115.018544.
    PubMed     Text format     Abstract available


  221. DOUGHERTY CM, Glenny RW, Burr RL, Flo GL, et al
    Response to Letter Regarding Article, "Prospective Randomized Trial of Moderately Strenuous Aerobic Exercise After an Implantable Cardioverter Defibrillator".
    Circulation. 2015;132:e381.
    PubMed     Text format    


  222. AYOUB K
    Letter by Ayoub Regarding Article, "Prospective Randomized Trial of Moderately Strenuous Aerobic Exercise After an Implantable Cardioverter Defibrillator".
    Circulation. 2015;132:e380.
    PubMed     Text format    


  223. LINDVALL C, Chatterjee NA, Chang Y, Chernack B, et al
    National Trends in the Utilization of Cardiac Resynchronization Therapy With or Without Implantable-Cardioverter Defibrillator.
    Circulation. 2015 Dec 3. pii: CIRCULATIONAHA.115.018830.
    PubMed     Text format     Abstract available


  224. ABDUL-RAHIM AH, Perez AC, Fulton RL, Jhund PS, et al
    Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopr
    Circulation. 2015;132:e358.
    PubMed     Text format    


  225. LIN GM, Hung Y, Li YH
    Letter by Lin et al Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sop
    Circulation. 2015;132:e357.
    PubMed     Text format    


  226. MARON BJ, Udelson JE, Bonow RO, Nishimura RA, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scie
    Circulation. 2015;132:e273-80.
    PubMed     Text format    


  227. LINK MS, Mark Estes NA 3rd, Maron BJ
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 13: Commotio Cordis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Circulation. 2015;132:e339-42.
    PubMed     Text format    


  228. ZIPES DP, Link MS, Ackerman MJ, Kovacs RJ, et al
    Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects: A Scientific Statement From the American Heart Association and American College of Cardiolog
    Circulation. 2015;132:e315-25.
    PubMed     Text format    


    November 2015
  229. SARRIAS A, Villuendas R, Bisbal F, Pereferrer D, et al
    From Atrial Fibrillation to Ventricular Fibrillation and Back.
    Circulation. 2015;132:2035-6.
    PubMed     Text format    


  230. PODRID PJ
    ECG Response: November 10, 2015.
    Circulation. 2015;132:1846.
    PubMed     Text format    


  231. DE CAEN AR, Berg MD, Chameides L, Gooden CK, et al
    Part 12: Pediatric Advanced Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2015;132.
    PubMed     Text format    


  232. LINK MS, Berkow LC, Kudenchuk PJ, Halperin HR, et al
    Part 7: Adult Advanced Cardiovascular Life Support: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
    Circulation. 2015;132.
    PubMed     Text format    


    October 2015
  233. COLIN GC, Vancraeynest D, Hoton D, Jonard P, et al
    Complete heart block caused by diffuse pseudotumoral cardiac involvement in granulomatosis with polyangiitis.
    Circulation. 2015;132:e207-10.
    PubMed     Text format    



  234. ECG response: October 27, 2015.
    Circulation. 2015;132:1679-80.
    PubMed     Text format    


  235. KUTYIFA V, Moss AJ, Klein H, Biton Y, et al
    Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
    Circulation. 2015;132:1613-9.
    PubMed     Text format     Abstract available


  236. TRAVERS AH, Perkins GD, Berg RA, Castren M, et al
    Part 3: Adult Basic Life Support and Automated External Defibrillation: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2015;132.
    PubMed     Text format    


  237. HAZINSKI MF, Nolan JP, Aickin R, Bhanji F, et al
    Part 1: Executive Summary: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations.
    Circulation. 2015;132.
    PubMed     Text format    


  238. FAGGIONI M, Knollmann BC
    Arrhythmia Protection in Hypokalemia: A Novel Role of Ca2+-Activated K+ Currents in the Ventricle.
    Circulation. 2015;132:1371-3.
    PubMed     Text format    


  239. CHAN YH, Tsai WC, Ko JS, Yin D, et al
    Small-Conductance Calcium-Activated Potassium Current Is Activated During Hypokalemia and Masks Short-Term Cardiac Memory Induced by Ventricular Pacing.
    Circulation. 2015;132:1377-86.
    PubMed     Text format     Abstract available


  240. PODRID PJ
    ECG Response: October 6, 2015.
    Circulation. 2015;132:1365.
    PubMed     Text format    


    September 2015

  241. ECG Response: September 22, 2015.
    Circulation. 2015;132:1152-3.
    PubMed     Text format    


  242. POTERUCHA TJ, Bergmark B, Aranki S, Kaneko T, et al
    Surgical Pulmonary Embolectomy.
    Circulation. 2015;132:1146-51.
    PubMed     Text format    


  243. REA TD
    Science of Cardiopulmonary Resuscitation: Just Scratching the Surface.
    Circulation. 2015;132:994-6.
    PubMed     Text format    


  244. TASKESEN T, Goldberg SL, Mannelli L, Rabkin D, et al
    Granulomatosis With Polyangiitis Presenting With an Intracardiac Mass and Complete Heart Block: Enhanced Images by 3-Dimensional Echocardiography.
    Circulation. 2015;132:961-4.
    PubMed     Text format    



  245. ECG Response: September 8, 2015.
    Circulation. 2015;132:960.
    PubMed     Text format    


  246. CALKINS H
    Demonstrating the Value of Contact Force Sensing: More Difficult Than Meets the Eye.
    Circulation. 2015;132:901-3.
    PubMed     Text format    


    August 2015
  247. PIZZI MN, Roque A, Fernandez-Hidalgo N, Cuellar-Calabria H, et al
    Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices with 18F-FDG-PET/CT-Angiography: Initial Results at an Infective Endocarditis Referral Center.
    Circulation. 2015 Aug 14. pii: CIRCULATIONAHA.115.015316.
    PubMed     Text format     Abstract available


    July 2015
  248. SEIFFGE DJ, Van Hooff RJ, Nolte CH, Bejot Y, et al
    Recanalization Therapies in Acute Ischemic Stroke Patients: Impact of Prior Treatment with Novel Oral Anticoagulants on Bleeding Complications and Outcome - A Pilot Study.
    Circulation. 2015 Jul 31. pii: CIRCULATIONAHA.115.015484.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: